Medical Excellence Capital Partners, LP — Form D/A
Medical Excellence Capital Partners, LP of NISSEQUOGUE, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2022-03-16. The offering totals $250.0M, of which $114.4M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-03-16
- Form: D/A
- Accession: 0001823093-22-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $250.0M
- Amount sold: $114.4M
- Remaining: $135.6M
- Minimum investment: $1
- Investors: 8
- Date of first sale: 2020-11-19
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-381032
Issuer
- Name: Medical Excellence Capital Partners, LP
- CIK: 0001823093
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: C/O MEDICAL EXCELLENCE CAPITAL, LLC, NISSEQUOGUE, NY, 11780
- Phone: 212-884-0584
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| John Prufeta | Executive Officer | New York, NY |
| John Prufeta | Promoter | New York, NY |
| N/A Medical Excellence Capital, LLC | Executive Officer | Nissequogue, NY |
| N/A Medical Excellence GP, LLC | Director | Nissequogue, NY |
| N/A Medical Excellence GP, LLC | Executive Officer | Nissequogue, NY |
| N/A ICT Holding, Ltd. | Promoter | Limassol, G4 |
| N/A Siracusa Holdings, LLC | Executive Officer | Nissequogue, NY |
| N/A Siracusa Holdings, LLC | Promoter | Nissequogue, NY |
Other filings by this issuer (2)
More